Evidence map›Paper›PMID 33014686›Full record

Article3 Biotech2020

Botrops derived hemocoagulase formulation a probable agent for diabetic wound healing.

Raghuvir Keni, Karthik Gourishetti, Manas Kinra, Pawan G Nayak, Rekha Shenoy, Krishnadas Nandakumar, Rajesh N Jagdale, K V Raghavendra, Syed Mushtaq Ahmed

Open access · hybridAbstract read
In one paragraph

Article in 3 Biotech, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Raghuvir Keni *Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104 Karnataka India.ORCID 0000-0001-8547-6355
Karthik Gourishetti *Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104 Karnataka India.ORCID https://orcid.org/0000-0001-5262-0883
Manas KinraDepartment of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104 Karnataka India.ORCID 0000-0001-8479-6998
Pawan G NayakDepartment of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104 Karnataka India.ORCID 0000-0001-5525-9982
Rekha ShenoyDepartment of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104 Karnataka India.ORCID 0000-0001-7684-1242
Krishnadas NandakumarDepartment of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104 Karnataka India.ORCID 0000-0001-6653-4660
Rajesh N JagdaleJuggat Pharma, Jagdale Industries Pvt. Ltd., Bengaluru, 560078 Karnataka India.
K V RaghavendraJuggat Pharma, Jagdale Industries Pvt. Ltd., Bengaluru, 560078 Karnataka India.
Syed Mushtaq AhmedJuggat Pharma, Jagdale Industries Pvt. Ltd., Bengaluru, 560078 Karnataka India.
Manipal Academy of Higher Education · INJDA Software (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Botroclot is a marketed preparation containing hemocoagulase, which is an enzyme having coagulant activity, isolated from the snake

Indexed as

Botrops atroxDiabetic woundHemocoagulaseVenom

Identifiers

PMID33014686
PMCPMC7501396
OpenAlexW3087144008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.